America First Investment Advisors LLC Cuts Stake in CME Group Inc (NASDAQ:CME)

America First Investment Advisors LLC lowered its holdings in shares of CME Group Inc (NASDAQ:CME) by 1.4% during the second quarter, …

CME Group logoAmerica First Investment Advisors LLC lowered its holdings in shares of CME Group Inc (NASDAQ:CME) by 1.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 87,734 shares of the financial services provider’s stock after selling 1,256 shares during the quarter. CME Group comprises about 5.2% of America First Investment Advisors LLC’s investment portfolio, making the stock its 5th biggest position. America First Investment Advisors LLC’s holdings in CME Group were worth $17,030,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Truvestments Capital LLC bought a new position in shares of CME Group during the 1st quarter valued at $32,000. Westside Investment Management Inc. bought a new position in CME Group in the 2nd quarter worth $38,000. Close Asset Management Ltd bought a new position in CME Group in the 1st quarter worth $34,000. Permanens Capital L.P. bought a new position in CME Group in the 1st quarter worth $41,000. Finally, Berman Capital Advisors LLC raised its holdings in CME Group by 23.9% in the 1st quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock worth $56,000 after acquiring an additional 66 shares during the period. Institutional investors and hedge funds own 84.58% of the company’s stock.

In other news, insider Hilda Harris Piell sold 1,132 shares of the business’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $188.05, for a total transaction of $212,872.60. Following the transaction, the insider now owns 33,011 shares in the company, valued at approximately $6,207,718.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Derek Sammann sold 6,400 shares of the business’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $198.83, for a total transaction of $1,272,512.00. Following the transaction, the insider now owns 25,177 shares in the company, valued at approximately $5,005,942.91. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 78,873 shares of company stock worth $15,707,799. Insiders own 1.20% of the company’s stock.

Shares of CME opened at $208.89 on Thursday. The company has a market cap of $74.64 billion, a P/E ratio of 30.63, a PEG ratio of 4.58 and a beta of 0.23. CME Group Inc has a one year low of $161.05 and a one year high of $210.17. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. The stock has a fifty day moving average price of $201.54.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the firm posted $1.74 EPS. The business’s revenue was up 20.1% compared to the same quarter last year. As a group, equities research analysts forecast that CME Group Inc will post 6.66 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.44%. CME Group’s payout ratio is 43.99%.

CME has been the topic of several recent analyst reports. Rosenblatt Securities downgraded shares of CME Group from a “neutral” rating to a “sell” rating in a report on Thursday, April 18th. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a report on Monday, May 27th. UBS Group lifted their target price on shares of CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a report on Wednesday, July 3rd. Wells Fargo & Co lifted their target price on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd. Finally, Citigroup set a $202.00 target price on shares of CME Group and gave the stock a “buy” rating in a report on Thursday, May 2nd. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $192.14.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Further Reading: What are the disadvantages of after-hours trading?

Want to see what other hedge funds are holding CME?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Coinbase Must Face Negligence Suit Over Bitcoin Cash Launch, Judge Rules

Coinbase must face a negligence lawsuit from customers who bought bitcoin cash (BCH) following its allegedly botched listing on the exchange …

Coinbase must face a negligence lawsuit from customers who bought bitcoin cash (BCH) following its allegedly botched listing on the exchange during the 2017 bull market, a judge has ruled.

U.S. District Judge Vince Chhabaria of the Northern District of California dismissed the plaintiffs’ fraud and unfair competition claims against Coinbase, and the negligence claims brought by the ones who sold BCH. But he denied Coinbase’s motions to move the case to arbitration and to dismiss the buyers’ negligence claims, saying it is “plausible” that the company “breached its duty to maintain a functional market.”

“For starters, the fact that Coinbase halted trading within three minutes of the launch is indicative of dysfunction,” Chhabria wrote in the rulingTuesday.

The case was brought last year by Jeffrey Berk, a former Coinbase user, who accused the exchange of allowing insider trading on its GDAX trading platform from Dec. 19–21, 2017, because BCH prices spiked right before Coinbase announced trading options on Dec. 20. Berk, an Arizona resident, brought the case on behalf of other traders. Two earlier versions of his complaint were dismissed.

In dismissing the insider trading theory, Chhabria cited a lack of “causation” proved by the plaintiff’s price volatility arguments. (Last year, the exchange hired two law firms to investigate insider trading allegations; they reportedly found no wrongdoing.)

Standard of care

Nevertheless, Coinbase will need to prove it applied a standard of reasonable care to prevent foreseeable harm to users.

Coinbase contested that it had a “duty” to strategize against market swings, citing a lack of responsibility to prevent the economic loss of others. The judge’s order replied, “the interpretation that the California Supreme Court would be most likely to adopt – is that Coinbase indeed had a duty to maintain a functional marketplace.”

Namely, because Coinbase “encouraged traders to enter the market,” by promoting the BCH launch, and held a “position of trust” when processing users’ transactions.

Because the sellers’ motion was dismissed with prejudice, it cannot be amended. However, the discovery process will continue, and Chhabria left a door open for the sellers to re-file should new evidence to support their position turn up.

Coinbase CEO Brian Armstrong image via CoinDesk archives.

Related Posts:

  • No Related Posts

Mn Services Vermogensbeheer BV Sells 3600 Shares of Iqvia Holdings Inc (NYSE:IQV)

AQR Capital Management LLC lifted its stake in Iqvia by 18.2% in the first quarter. AQR Capital Management LLC now owns 3,642,793 shares of the …

Iqvia logoMn Services Vermogensbeheer B.V. reduced its stake in shares of Iqvia Holdings Inc (NYSE:IQV) by 4.0% in the second quarter, HoldingsChannel.com reports. The firm owned 86,034 shares of the medical research company’s stock after selling 3,600 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Iqvia were worth $13,843,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in IQV. BlackRock Inc. lifted its stake in Iqvia by 12.0% in the first quarter. BlackRock Inc. now owns 12,290,692 shares of the medical research company’s stock valued at $1,768,016,000 after purchasing an additional 1,313,508 shares during the last quarter. FMR LLC lifted its stake in Iqvia by 27.5% in the first quarter. FMR LLC now owns 5,376,239 shares of the medical research company’s stock valued at $773,372,000 after purchasing an additional 1,158,248 shares during the last quarter. AQR Capital Management LLC lifted its stake in Iqvia by 18.2% in the first quarter. AQR Capital Management LLC now owns 3,642,793 shares of the medical research company’s stock valued at $519,972,000 after purchasing an additional 561,276 shares during the last quarter. Geode Capital Management LLC lifted its stake in Iqvia by 8.4% in the fourth quarter. Geode Capital Management LLC now owns 2,130,570 shares of the medical research company’s stock valued at $247,087,000 after purchasing an additional 164,811 shares during the last quarter. Finally, Lazard Asset Management LLC lifted its stake in Iqvia by 9.7% in the first quarter. Lazard Asset Management LLC now owns 1,942,415 shares of the medical research company’s stock valued at $279,414,000 after purchasing an additional 172,067 shares during the last quarter. Hedge funds and other institutional investors own 90.38% of the company’s stock.

Several equities analysts recently commented on the company. Stifel Nicolaus upped their price objective on Iqvia from $167.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, June 19th. Zacks Investment Research upgraded Iqvia from a “sell” rating to a “hold” rating in a research note on Friday, May 3rd. Mizuho upgraded Iqvia from a “neutral” rating to a “buy” rating and upped their price objective for the company from $150.00 to $175.00 in a research note on Friday, June 21st. William Blair reiterated an “outperform” rating on shares of Iqvia in a research note on Wednesday, June 19th. Finally, Credit Suisse Group increased their target price on Iqvia from $165.00 to $170.00 and gave the stock an “outperform” rating in a research report on Thursday, July 25th. Three research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $161.13.

In other news, insider Ari Bousbib sold 96,000 shares of the company’s stock in a transaction on Friday, June 28th. The shares were sold at an average price of $160.00, for a total value of $15,360,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Kevin C. Knightly sold 6,945 shares of the company’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $158.53, for a total transaction of $1,100,990.85. The disclosure for this sale can be found here. In the last ninety days, insiders sold 198,945 shares of company stock worth $30,860,991. Insiders own 6.00% of the company’s stock.

NYSE:IQV opened at $151.80 on Tuesday. The stock has a market capitalization of $30.77 billion, a P/E ratio of 29.65, a P/E/G ratio of 1.91 and a beta of 0.88. The stock’s fifty day moving average is $157.55. Iqvia Holdings Inc has a 1 year low of $104.90 and a 1 year high of $164.13. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.72.

Iqvia (NYSE:IQV) last posted its earnings results on Wednesday, July 24th. The medical research company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.38 by $0.01. The firm had revenue of $2.74 billion for the quarter, compared to the consensus estimate of $2.70 billion. Iqvia had a return on equity of 15.95% and a net margin of 2.31%. The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.29 earnings per share. Equities analysts forecast that Iqvia Holdings Inc will post 5.86 earnings per share for the current year.

Iqvia Company Profile

IQVIA Holdings Inc provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Featured Story: Why do earnings reports matter?

Want to see what other hedge funds are holding IQV?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).

Institutional Ownership by Quarter for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Iqvia and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Artemis Investment Management LLP Sells 21995 Shares of 2U Inc (NASDAQ:TWOU)

Artemis Investment Management LLP cut its stake in 2U Inc (NASDAQ:TWOU) by 20.9% in the second quarter, according to its most recent Form 13F …

2U logoArtemis Investment Management LLP cut its stake in 2U Inc (NASDAQ:TWOU) by 20.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 83,170 shares of the software maker’s stock after selling 21,995 shares during the quarter. Artemis Investment Management LLP’s holdings in 2U were worth $3,040,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in TWOU. Sigma Planning Corp boosted its position in shares of 2U by 6.5% in the first quarter. Sigma Planning Corp now owns 4,320 shares of the software maker’s stock worth $306,000 after purchasing an additional 262 shares during the period. Oppenheimer & Co. Inc. boosted its position in shares of 2U by 7.0% in the first quarter. Oppenheimer & Co. Inc. now owns 5,272 shares of the software maker’s stock worth $374,000 after purchasing an additional 345 shares during the period. California State Teachers Retirement System boosted its position in shares of 2U by 0.5% in the first quarter. California State Teachers Retirement System now owns 86,531 shares of the software maker’s stock worth $6,131,000 after purchasing an additional 392 shares during the period. NEXT Financial Group Inc boosted its position in shares of 2U by 39.5% in the second quarter. NEXT Financial Group Inc now owns 1,679 shares of the software maker’s stock worth $64,000 after purchasing an additional 475 shares during the period. Finally, Meridian Wealth Management LLC bought a new position in shares of 2U in the first quarter worth approximately $50,000.

Shares of TWOU opened at $13.87 on Tuesday. 2U Inc has a twelve month low of $11.37 and a twelve month high of $90.31. The stock has a market capitalization of $866.42 million, a P/E ratio of -22.02 and a beta of 0.84. The company has a current ratio of 2.19, a quick ratio of 5.11 and a debt-to-equity ratio of 0.35. The company has a fifty day moving average price of $35.01.

2U (NASDAQ:TWOU) last posted its quarterly earnings results on Tuesday, July 30th. The software maker reported ($0.43) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.59) by $0.16. The firm had revenue of $135.50 million for the quarter, compared to analysts’ expectations of $124.38 million. 2U had a negative net margin of 11.39% and a negative return on equity of 7.63%. The business’s revenue for the quarter was up 39.1% on a year-over-year basis. During the same period in the prior year, the business posted ($0.19) earnings per share. As a group, sell-side analysts forecast that 2U Inc will post -2.13 EPS for the current year.

In other 2U news, insider Matthew J. Norden sold 1,650 shares of the stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $39.31, for a total transaction of $64,861.50. Following the transaction, the insider now directly owns 14,142 shares in the company, valued at approximately $555,922.02. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider James Kenigsberg sold 7,353 shares of the stock in a transaction dated Friday, July 12th. The stock was sold at an average price of $38.91, for a total transaction of $286,105.23. Following the transaction, the insider now owns 142,341 shares in the company, valued at $5,538,488.31. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 9,155 shares of company stock worth $356,942. 4.92% of the stock is owned by company insiders.

A number of equities analysts have weighed in on the stock. DA Davidson lowered shares of 2U from a “buy” rating to a “neutral” rating and set a $27.00 price target for the company. in a research report on Wednesday, July 31st. Macquarie lowered shares of 2U from an “outperform” rating to a “neutral” rating and set a $29.00 price target for the company. in a research report on Wednesday, July 31st. Barrington Research lowered shares of 2U from an “outperform” rating to a “market perform” rating in a research report on Wednesday, July 31st. Piper Jaffray Companies dropped their price target on shares of 2U from $78.00 to $57.00 and set a “neutral” rating for the company in a research report on Wednesday, May 8th. Finally, Needham & Company LLC lowered shares of 2U from a “buy” rating to a “hold” rating in a research report on Wednesday, July 31st. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $49.08.

2U Company Profile

2U, Inc operates as an education technology company in the United States, Hong Kong, South Africa, and the United Kingdom. The company operates through two segments, Graduate Program Segment and Short Course Segment. It offers front-end technology and services, including online learning platform, student and faculty and immersion support, accessibility, admissions application advising, in-program student field placements, and faculty recruiting.

Read More: What are the advantages of the Stochastic Momentum Index?

Want to see what other hedge funds are holding TWOU?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 2U Inc (NASDAQ:TWOU).

Institutional Ownership by Quarter for 2U (NASDAQ:TWOU)

Receive News & Ratings for 2U Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for 2U and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Artemis Investment Management LLP Reduces Stock Position in 2U Inc (NASDAQ:TWOU)

Artemis Investment Management LLP reduced its holdings in shares of 2U Inc (NASDAQ:TWOU) by 20.9% during the second quarter, according to its …

2U logoArtemis Investment Management LLP reduced its holdings in shares of 2U Inc (NASDAQ:TWOU) by 20.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 83,170 shares of the software maker’s stock after selling 21,995 shares during the quarter. Artemis Investment Management LLP owned about 0.14% of 2U worth $3,040,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Daiwa Securities Group Inc. purchased a new stake in shares of 2U during the 2nd quarter valued at approximately $33,000. Meridian Wealth Management LLC purchased a new stake in shares of 2U during the 1st quarter valued at approximately $50,000. Icon Wealth Partners LLC purchased a new stake in shares of 2U during the 1st quarter valued at approximately $55,000. NEXT Financial Group Inc lifted its stake in shares of 2U by 39.5% during the 2nd quarter. NEXT Financial Group Inc now owns 1,679 shares of the software maker’s stock valued at $64,000 after buying an additional 475 shares in the last quarter. Finally, FUKOKU MUTUAL LIFE INSURANCE Co purchased a new stake in shares of 2U during the 1st quarter valued at approximately $85,000.

2U stock opened at $13.87 on Tuesday. The firm’s fifty day moving average is $35.01. The company has a debt-to-equity ratio of 0.35, a quick ratio of 5.11 and a current ratio of 2.19. The stock has a market cap of $866.42 million, a PE ratio of -22.02 and a beta of 0.84. 2U Inc has a fifty-two week low of $11.37 and a fifty-two week high of $90.31.

2U (NASDAQ:TWOU) last posted its quarterly earnings data on Tuesday, July 30th. The software maker reported ($0.43) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.59) by $0.16. The firm had revenue of $135.50 million for the quarter, compared to analysts’ expectations of $124.38 million. 2U had a negative net margin of 11.39% and a negative return on equity of 7.63%. The business’s quarterly revenue was up 39.1% on a year-over-year basis. During the same quarter last year, the company posted ($0.19) EPS. On average, equities research analysts forecast that 2U Inc will post -2.13 EPS for the current year.

In other 2U news, Director Gregory K. Peters bought 12,459 shares of 2U stock in a transaction that occurred on Tuesday, May 14th. The shares were bought at an average price of $40.15 per share, with a total value of $500,228.85. Following the acquisition, the director now owns 25,744 shares in the company, valued at $1,033,621.60. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Matthew J. Norden sold 1,650 shares of the stock in a transaction on Friday, May 10th. The shares were sold at an average price of $39.31, for a total transaction of $64,861.50. Following the transaction, the insider now directly owns 14,142 shares in the company, valued at approximately $555,922.02. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 9,155 shares of company stock worth $356,942. Corporate insiders own 4.92% of the company’s stock.

Several research firms have issued reports on TWOU. DA Davidson cut shares of 2U from a “buy” rating to a “neutral” rating and set a $27.00 target price on the stock. in a research note on Wednesday, July 31st. Oppenheimer cut shares of 2U from an “outperform” rating to a “market perform” rating in a research note on Wednesday, July 31st. Barrington Research cut shares of 2U from an “outperform” rating to a “market perform” rating in a research note on Wednesday, July 31st. KeyCorp began coverage on shares of 2U in a research note on Tuesday, July 16th. They issued an “overweight” rating and a $56.00 target price on the stock. Finally, TheStreet cut shares of 2U from a “c-” rating to a “d” rating in a research note on Tuesday, May 21st. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $49.08.

2U Profile

2U, Inc operates as an education technology company in the United States, Hong Kong, South Africa, and the United Kingdom. The company operates through two segments, Graduate Program Segment and Short Course Segment. It offers front-end technology and services, including online learning platform, student and faculty and immersion support, accessibility, admissions application advising, in-program student field placements, and faculty recruiting.

Featured Article: Is the Dow Jones Industrial Average (DJIA) still relevant?

Want to see what other hedge funds are holding TWOU?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 2U Inc (NASDAQ:TWOU).

Institutional Ownership by Quarter for 2U (NASDAQ:TWOU)

Receive News & Ratings for 2U Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for 2U and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts